Trust is a cornerstone of effective health systems, influencing every interaction between the public and healthcare providers. This Jawdrop Fireside will explore how enhancing trust can lead to better public health outcomes and bolster the success of the UK Life Sciences sector.
It builds on previous Jawdrop themes, such as optimising clinical trials and strengthening the UK’s resilience against antimicrobial resistance (AMR) and future pandemics and aims to delve into the pivotal role of trust more broadly including around health in local communities.
PANEL 1: Engaging Communities and Building Trust for Vaccines
Childhood vaccination rates in the UK have dipped, with no vaccines meeting the 95% target and the country seeing a re-emergence of measles, a previously eradicated illness. Globally, the picture is mixed, with rates for long standing vaccines including BCG and HepB3 falling, others remaining stable or, in the case of new vaccines, inching up.
In the UK, vaccine uptake has benefited through active public health campaigns. Yet, such progress is threatened by factors including the easy and rapid spread of online disinformation. It is also hindered by the growing mistrust in government and dissatisfaction with the NHS. Our panel consists of public health practitioners, vaccine-makers and academics, all of whom seek to build strong relationships and trust, through different channels and means.
Panelists:
Dr Nicola Lang, Director of Public Health for H&F Council
Dr Philip Cruz – Moderna UK, Country Medical Director
Dr Andrew Cai, Medical Director of UK and Republic of Ireland, CSL Seqirus.
Phayza Fudlulla, BME Health Forum
Chair: Professor Helen Ward, Professor of Public Health, School of Public Health, Imperial
PANEL 2: Engaging Communities and Building Trust for Clinical Research
Clinical research is essential for advancing medical knowledge and developing new treatments. The 2022/23 CRN annual statistics show research participation levels have increased on pre-pandemic levels. Almost one million participants (952,789) took part in clinical research across England. This is an increase of over 220,000 on pre-pandemic levels.
However, patient trust in clinical research can be fragile, influenced by factors such as past unethical studies, lack of transparency, and concerns about privacy and safety. In the UK, a global hub for medical research, initiatives to rebuild and enhance this trust are particularly crucial. London’s diverse population and advanced healthcare infrastructure make it an ideal setting for clinical trials, but these same factors also present unique challenges.
Panelists:
Naima Adan, Community Engagement Officer, Patient Experience Research Centre (PERC)
Luke Devey, BMBCh, Ph.D., Chief Medical Officer, Quell Tx
Pauline Hakutangwi, Novartis UK – patient engagement representative
Dr. Keerti Gedela, EDI Lead, CRN North West London
CHAIR: Dr Bob Klaber, Consultant General Paediatrician and Executive Director of Strategy, Research and Innovation, Imperial College Healthcare NHS Trust
Please choose the correct ticket type as we want to ensure the right mix of attendees. Incorrect and incomplete forms will be rejected.
White City Innovation District: Home to world-leading researchers and ground-breaking enterprises working on today’s greatest challenges and shaping tomorrow’s world: https://www.whitecityinnovationdistrict.org.uk
Attendance Application Disclaimer
1. Organiser’s Discretion
– The organisers reserve the right to accept or reject any application to attend without providing reasons.
– Decisions made by the organisers are final and not subject to appeal.
2. Changes and Cancellations
– The organisers reserve the right to make changes to the event details, including the schedule and venue, or to cancel the event if necessary. Approved applicants will be informed of any significant changes.
By applying for a ticket, you acknowledge and agree to the terms and conditions outlined in this disclaimer. If you have any questions or require further information, please contact us at hello@move-upstream.org.uk